BCC Research Blog | Industry Analysis and Business Consulting

Diabetic Care Devices: Empowering Diabetes Management Worldwide

Written by Sandeep Singh Negi | Mar 26, 2025 1:00:00 PM

Introduction

Diabetes is a growing health concern worldwide. With more people being diagnosed yearly, managing this condition has become more important than ever. Thankfully, new technologies and devices make it easier for patients to monitor and control their blood sugar levels. The global diabetic care devices market is growing rapidly as these tools become more advanced and widely available.

What Are Diabetic Care Devices?

Diabetic care devices help patients manage diabetes in their daily lives. These devices fall into two main categories:

  1. Monitoring Devices – These include blood glucose meters, continuous glucose monitors (CGMs), and testing strips. They help track blood sugar levels throughout the day.
  2. Insulin Delivery Devices include insulin pens, pumps, and syringes, which deliver the insulin needed to control blood sugar.

Together, these devices help people with diabetes live healthier, more independent lives

Why Is the Market Growing?

Several key factors are driving the growth of the global diabetic care devices market:

  • Rising Diabetes Cases: Diabetes is becoming more common due to unhealthy lifestyles, poor diets, and aging populations. This means more people need tools to manage the condition.
  • Better Technology: Devices are becoming more accurate, easier to use, and even smarter. Some can connect to smartphones and track blood sugar levels in real-time.
  • Greater Awareness: People are more aware of diabetes and the importance of early diagnosis and proper care, which leads to increased demand for these devices.
  • Government Support: Many countries offer programs and financial support to make diabetic care more accessible.

Market Outlook and Numbers

According to Bcc Research, the global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029 at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029. Rising demand, technological innovation, and the increasing need for long-term diabetes management support this growth.